Vertex Pharmaceuticals VRTX has outperformed the market over the past 15 years by 8.2% on an annualized basis producing an average annual return of 14.17%. Currently, Vertex Pharmaceuticals has a market capitalization of $72.97 billion.
Buying $1000 In VRTX: If an investor had bought $1000 of VRTX stock 15 years ago, it would be worth $7,404.84 today based on a price of $284.52 for VRTX at the time of writing.
Vertex Pharmaceuticals’s Performance Over Last 15 Years
Finally — what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.